February 20, 2026 06:10 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
PM Modi warns ‘AI must not control humans’ as India unveils bold tech vision at AI Impact Summit 2026 | Former South Korean President Yoon Suk Yeol sentenced to life over failed martial law bid | Tata Group joins hands with OpenAI in massive AI push to transform India and global industries | Epstein Files row: Bill Gates to skip keynote address at AI Summit 2026 | AI Impact Summit: Google launches game-changing America-India Connect plan with $15 billion backing | AI takes centre stage as Modi meets Google CEO Sundar Pichai in Delhi | G7 Spotlight: Emmanuel Macron invites Narendra Modi for 2026 Summit | AI Summit embarrassment! Galgotias University asked to vacate stall after ‘own robot’ exposed as China’s Unitree Go2 | Actor Rajpal Yadav granted interim bail in ₹9-crore cheque bounce case | Learn AI or become redundant: Microsoft India President issues stark message
Pfizer
Image: Wikimedia Commons

Pfizer launches pilot COVID-19 vaccine distribution preparedness program in 4 US states

| @indiablooms | Nov 17, 2020, at 10:14 pm

Moscow/Sputnik: US pharmaceutical company Pfizer announced in a press release on Tuesday it was launching a pilot program that aims to inform the delivery and distribution of its coronavirus vaccine in the US states of Rhode Island, Texas, New Mexico and Tennessee.

"To build on our coordination with the relevant U.S. agencies, Pfizer launched this pilot program to help better support the states’ planning, deployment, and administration of the COVID-19 vaccine candidate. Learnings from this program will be adapted for usage across other states to help them create effective immunization programs for this vaccine," the company said in a press release.

According to Pfizer, the four US states were selected due to their differences in overall size, diversity of populations, and immunization infrastructure, as well as the need to reach populations both in rural and urban areas.

In a disclaimer of future preferential benefits for these four states, the company has stressed that they "will not receive vaccine doses earlier than other states by virtue of this pilot, nor will they receive any differential consideration."

Pfizer developed the vaccine in collaboration with German biotechnology company BioNTech. As the unregistered vaccine is underway with phase 3 clinical trials, the creators have declared above 90-percent efficiency.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.